Industry News | tctmd.com

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

News Industry News

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

February 26, 2018

News Industry News

AtriCure Launches the AtriClip® FLEX•V™ Device in the United States

February 23, 2018

News Industry News

LivaNova to Acquire TandemLife

February 22, 2018

News Industry News

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

February 20, 2018

News Industry News

Canon Medical Systems’ Vantage Galan 3T XGO Edition with All-New Saturn X Gradient Receives FDA Clearance

February 12, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

News Industry News

Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training

January 24, 2018

Subscribe to Industry News

Advertisement

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold

AtriCure Launches the AtriClip® FLEX•V™ Device in the United States

LivaNova to Acquire TandemLife

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

Canon Medical Systems’ Vantage Galan 3T XGO Edition with All-New Saturn X Gradient Receives FDA Clearance

SELUTION™ First-in-Man Study Achieves Primary Endpoint

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content